$26.62
0.070.26%
Last update: 9:58 AM
15 minutes delayed
Comments
Loading...
Myriad Genetics (MYGN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMyriad Genetics (NASDAQ:MYGN) Stock Quotes, Forecast and News Summary
Myriad Genetics Stock (NASDAQ: MYGN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Myriad Genetics (MYGN) stock?
You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.
Who are Myriad Genetics (MYGN) competitors?
Other companies in Myriad Genetics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), Agios Pharmaceuticals (NASDAQ:AGIO) and Arrowhead Pharma (NASDAQ:ARWR).
What is the forecast, or price target, for Myriad Genetics (MYGN) stock?
Myriad Genetics has a consensus price target of $27.57.
What is the current price for Myriad Genetics (MYGN)?
The stock price for Myriad Genetics (NASDAQ: MYGN) is $26.62 last updated September 25, 2024 at 9:58 AM EDT.
Does Myriad Genetics (MYGN) pay a dividend?
There are no upcoming dividends for Myriad Genetics.
When is Myriad Genetics (NASDAQ:MYGN) reporting earnings?
Myriad Genetics’s Q3 earnings are confirmed for Monday, November 4, 2024.
Is Myriad Genetics (MYGN) going to split?
There is no upcoming split for Myriad Genetics.
What sector and industry does Myriad Genetics (MYGN) operate in?
Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.